Researchers at UNC Health Care have found that using a new method for identifying bacteria and fungi in patient specimens led to a 92 percent cost reduction in the reagents needed to run clinical microbiology tests.
During the year-long study, the new technology – called MALDI-TOF MS – was also found to take much less time. In most cases, lab technologists identified a pathogen in about an hour; test results from conventional molecular methods take at least a day and often longer.
“This is a big deal,” Gilligan said. “Doctors would see patients with chronic infections and no one knew what caused them. Now we know and we can treat patients much more effectively than before.”
Read more . . .
The Latest on: Pathogen identification
[google_news title=”” keyword=”Pathogen identification” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pathogen identification
- How Gut Epithelial Cells Defend Against Deadly Diarrheal Infectionson May 8, 2024 at 2:16 am
A study brings new understanding to how absorptive intestinal epithelial cells, or IECs, and T cells work together to defend the gut barrier.
- Loss of large herbivores affects interactions between plants and their natural enemies, study showson May 7, 2024 at 7:33 am
Insects and microorganisms that feed on plants, cut up leaves, modify leaf tissue or produce leaf spots and other kinds of damage, are usually known as pests and considered harmful, yet interactions ...
- Key role found for gut epithelial cells in the defense against deadly diarrheal infectionson May 7, 2024 at 7:14 am
Intestinal epithelial cells line the inner wall of the gut, creating a barrier against dangerous bacteria like enteropathogenic E. coli that seek to attach to and destroy this barrier. Such pathogens ...
- Faces of Food Safety: Meet Dayna M. Harhay of the Animal Research Centeron May 5, 2024 at 5:00 pm
identification, and prevention of Salmonella bacteria and other foodborne pathogens that can be associated with beef products. Isn’t Salmonella a Chicken Problem? Harhay smiles as she looks back at ...
- Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing ...on May 2, 2024 at 12:00 pm
Karius®, Inc., a world leader in genomic diagnostics for infectious disease, today announced it has secured $100 million in Series C funding. The roun ...
- Spanish Startup DeepUll Unveils MDx Platform, Direct-From-Blood Sepsis Assay at ESCMID Globalon April 29, 2024 at 3:00 am
DeepUll showcased its UllCore platform and UllCore BSI Test, a one-hour multiplex PCR assay targeting 95 percent of sepsis-causing pathogens and multiple antibiotic resistance genes.
- Study rethinks immune system strategies to boost vaccine effectivenesson April 28, 2024 at 9:52 pm
A recent Cell journal review explores key immunological assumptions to enhance our understanding of vaccine design, autoimmune responses, and immune system pathology, aiming to refine intervention ...
- The JRC explains: technologies for fighting airborne germs - PCR, sequencing, and the reston April 26, 2024 at 3:10 am
During the COVID-19 pandemic, most of us made a rather intimate acquaintance with some of these technologies. And many of us are still confused about ...
- deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024on April 25, 2024 at 12:28 am
UllCORE is designed to transform life-saving clinical decision making for sepsis patients Barcelona, Spain – 25 April 2024 – deepull, a medical diagnostics company developing culture-free diagnostic ...
- Updated WHO Pandemic Accord Retains Commitments for Non-Exclusive Licensing and Royalty Waiverson April 24, 2024 at 8:15 am
“[T]he current draft of the WHO pandemic agreement appears to foreclose the possibility of IP rights accruing from pathogen research shared under the agreement.” On April 19, the World Health ...
via Bing News